Comparing Anoro Ellipta vs Ohtuvayre
| Anoro Ellipta (umeclidinium / vilanterol) | Ohtuvayre (ensifentrine) |
|
|---|
| Anoro Ellipta (umeclidinium / vilanterol) | Ohtuvayre (ensifentrine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Anoro Ellipta is a once-daily inhalation that may be used to help maintain airway opening in adults with COPD. It is well-tolerated with few side effects, but it should not be used to treat asthma... View more |
Prescription only
Prescribed for COPD - Maintenance, COPD. Ohtuvayre may also be used for purposes not listed in this medication guide. |
Related suggestions COPD
COPD, Maintenance
Popular comparisons
|
|||||||||||||||
| More about Anoro Ellipta (umeclidinium / vilanterol) | More about Ohtuvayre (ensifentrine) | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Anoro Ellipta has an average rating of 7.1 out of 10 from a total of 69 ratings on Drugs.com. 59% of reviewers reported a positive effect, while 22% reported a negative effect. |
Ohtuvayre has an average rating of 9.0 out of 10 from a total of 4 ratings on Drugs.com. 75% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
View all Anoro Ellipta side effects |
View all Ohtuvayre side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Anoro Ellipta prices |
View all Ohtuvayre prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
21.3 hours |
12.6 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 500 drugs are known to interact with Anoro Ellipta:
|
A total of 40 drugs are known to interact with Ohtuvayre:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
| Disease Interactions | |||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||||||||||
| First Approval Date | |||||||||||||||||
|
December 18, 2013 |
June 26, 2024 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
|||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.